Spontaneous Coronary Artery Dissection (SCAD) Avatar Study
1 other identifier
observational
150
1 country
1
Brief Summary
The purpose of this study is to evaluate patient satisfaction, comfort, and trust in interacting with an avatar compared with speaking to a human clinician during a pre clinical visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
June 30, 2026
June 1, 2026
1.8 years
March 23, 2026
June 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Satisfaction
Patient satisfaction with the AI avatar (Visual/Voice and Voice only) will be assessed using a structured questionnaire completed after the AI-conducted pre-interview. Responses will be measured on a numeric Likert scale (1-5), with higher scores indicating greater satisfaction and comfort with the AI avatar interaction.
Baseline
Study Arms (3)
Video Avatar
Voice-Only Avatar
Human Interview
Interventions
Patients will undergo a pre-visit interview with a Video Avatar (LLM powered digital interviewer presented with on-screen video)
Patients will undergo a pre-visit interview with a Voice-Only Avatar ( LLM-powered interviewer delivered without visuals)
Patients will undergo a Human Interview conducted by trained Mayo personnel
Eligibility Criteria
Eligible SCAD patients will be identified once they have a confirmed Mayo Clinic SCAD Clinic appointment
You may qualify if:
- All patients scheduled for a SCAD appointment at Mayo Clinic
You may not qualify if:
- Not Applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Sharonne Hayes, M.D
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
June 30, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share